Movement disorders: An update

被引:1
作者
Bereau, M. [1 ]
Tranchant, C. [2 ,3 ]
机构
[1] CHRU Besancon, Hop Jean Minjoz, Serv Neurol, 3 Blvd Alexandre Fleming, F-25030 Besancon, France
[2] CHU Strasbourg, Hop Hautepierre, Serv Neurol, 1 Ave Moliere, F-67200 Strasbourg, France
[3] Univ Strasbourg 1, INSERM, IGBMC, CNRS,UMR7104,U964, Rue Laurent Fries, F-67400 Illkirch Graffenstaden, France
来源
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 08期
关键词
Movement disorders; Basal ganglia; Treatable metabolic diseases; Neurogenetics; Deep brain stimulation; DRUG-INDUCED DYSKINESIA; HUNTINGTONS-DISEASE; ESSENTIAL TREMOR; NEURODEGENERATION; DIAGNOSIS; DYSTONIA;
D O I
10.1016/j.revmed.2017.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Movement disorders (tremor, chorea, dystonia, tics, and myoclonus) are related to basal ganglia and/or interconnected brain areas dysfunction. Clinical examination is a key point in order to characterize the abnormal movement and identify associated signs that can guide etiological approach. latrogenic diseases will be systematically ruled out before conducting additional investigations (brain MRI, electrophysiological studies). Wilson disease, but also other treatable metabolic and/or genetic diseases, and auto-immune diseases will be systematically considered. Therapeutic management is symptomatic and based on specific oral drugs appropriate to each movement disorders. In some cases, radiosurgery and deep brain stimulation should be helpful, especially for tremor and generalized dystonia. (C) 2017 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:641 / 649
页数:9
相关论文
共 55 条
  • [1] Albanese A, 2017, LANCET NEUROL, V32, P1
  • [2] Phenomenology and classification of dystonia: A consensus update
    Albanese, Alberto
    Bhatia, Kailash
    Bressman, Susan B.
    DeLong, Mahlon R.
    Fahn, Stanley
    Fung, Victor S. C.
    Hallett, Mark
    Jankovic, Joseph
    Jinnah, Hyder A.
    Klein, Christine
    Lang, Anthony E.
    Mink, Jonathan W.
    Teller, Jan K.
    [J]. MOVEMENT DISORDERS, 2013, 28 (07) : 863 - 873
  • [3] Clinical neurophysiology of psychogenic movement disorders: How to diagnose psychogenic tremor and myoclonus
    Apartis, E.
    [J]. NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2014, 44 (04): : 417 - 424
  • [4] Baguma M, 2017, J MOV DISORD, V10, P96, DOI 10.14802/jmd.16055
  • [5] Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome
    Baizabal-Carvallo, Jose Fidel
    Bonnet, Cecilia
    Jankovic, Joseph
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (11) : 1579 - 1589
  • [6] Wilson's disease and other neurological copper disorders
    Bandmann, Oliver
    Weiss, Karl Heinz
    Kaler, Stephen G.
    [J]. LANCET NEUROLOGY, 2015, 14 (01) : 103 - 113
  • [7] Orthostatic Tremor: An Update on a Rare Entity
    Benito-Leon, Julian
    Domingo-Santos, Angela
    [J]. TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2016, 6
  • [8] Seminar on choreas
    Cardoso, Francisco
    Seppi, Klaus
    Mair, Katherina J.
    Wenning, Gregor K.
    Poewe, Werner
    [J]. LANCET NEUROLOGY, 2006, 5 (07) : 589 - 602
  • [9] Cardoso Francisco, 2017, J Neurol Neurosurg Psychiatry, V88, P412, DOI 10.1136/jnnp-2016-314475
  • [10] Primary and secondary dystonic syndromes: an update
    Charlesworth, Gavin
    Bhatia, Kailash P.
    [J]. CURRENT OPINION IN NEUROLOGY, 2013, 26 (04) : 406 - 412